Medicinal Chemistry of Anticancer Drugs
By- Carmen Avendano, Departamento de Química Orgánica y Farmacéutica, Facultad de Farmacia, Madrid, Spain
- J. Carlos Menendez, Departamento de Química Orgánica y Farmacéutica, Facultad de Farmacia, Universidad Complutense, Madrid, Spain
Antitumour chemotherapy is nowadays a very active field of research, and a huge amount of information on the topic is generated every year. Although many books are available that deal with clinical aspects of cancer chemotherapy, this book addresses the need for an updated treatment from the point of view of medicinal chemistry and drug design. Cytotoxic chemotherapy is gradually being supplemented by a new generation of drugs that recognize specific targets on the surface or inside cancer cells. These therapies are in their infancy, but they hold promise of more effective therapies with fewer side effects. Resistance to antitumour drugs is another important but normally neglected field. The focus of Medicinal Chemistry of Anticancer Drugs is on the mechanism of action of antitumour drugs from the molecular point of view and on the relationship between chemical structure and chemical and biochemical reactivity of antitumour agents, aiming at the rationalization of the action of this type of drugs, which would allow the design of new active structures.
Audience
For researchers in pharmaceutical, medicinal and organic chemistry departments in both academia and industry. Practitioners requiring an understanding of structure-activity relationships in oncology / cancer research. Advanced undergraduate and graduate students in medicinal chemistry and pharmacology.
Hardbound, 400 Pages
Published: April 2008
Imprint: Elsevier
ISBN: 978-0-444-52824-7
Contents
- 1. Introduction to anticancer chemotherapy
2. Antimetabolites
3. Anticancer drugs that inhibit hormone action
4. Anticancer drugs acting via radical species. Photosensitizers and photodynamic therapy of cancer.
5. DNA alkylating agents
6. Alkylating and non-alkylating compounds interacting with the DNA minor groove.
7. DNA intercalation and inhibition of topoisomerases
8. Anticancer drugs targeting tubulin and microtubules
9. Drugs targeting signaling pathways for tumour cell growth and proliferation
10.Other approaches to targeted therapy
11.Drug targeting in anticancer chemotherapy
12.Resistance to antitumour agents and drugs that modulate it
13.Cancer chemoprevention

